Ajooni Biotech Limited (AJOONI) - Net Assets
Based on the latest financial reports, Ajooni Biotech Limited (AJOONI) has net assets worth Rs910.85 Million INR (≈ $9.85 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs1.14 Billion ≈ $12.30 Million USD) and total liabilities (Rs226.46 Million ≈ $2.45 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AJOONI asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs910.85 Million |
| % of Total Assets | 80.09% |
| Annual Growth Rate | 119.09% |
| 5-Year Change | 462.78% |
| 10-Year Change | 16779.82% |
| Growth Volatility | 1317.68 |
Ajooni Biotech Limited - Net Assets Trend (2013–2025)
This chart illustrates how Ajooni Biotech Limited's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Ajooni Biotech Limited for the complete picture of this company's asset base.
Annual Net Assets for Ajooni Biotech Limited (2013–2025)
The table below shows the annual net assets of Ajooni Biotech Limited from 2013 to 2025. For live valuation and market cap data, see Ajooni Biotech Limited (AJOONI) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs880.79 Million ≈ $9.53 Million |
+106.23% |
| 2024-03-31 | Rs427.08 Million ≈ $4.62 Million |
+2.49% |
| 2023-03-31 | Rs416.69 Million ≈ $4.51 Million |
+154.35% |
| 2022-03-31 | Rs163.82 Million ≈ $1.77 Million |
+4.67% |
| 2021-03-31 | Rs156.51 Million ≈ $1.69 Million |
-1.51% |
| 2020-03-31 | Rs158.91 Million ≈ $1.72 Million |
+30.63% |
| 2019-03-31 | Rs121.65 Million ≈ $1.32 Million |
+11.16% |
| 2018-03-31 | Rs109.44 Million ≈ $1.18 Million |
+1028.79% |
| 2017-03-31 | Rs9.70 Million ≈ $104.85K |
+85.80% |
| 2016-03-31 | Rs5.22 Million ≈ $56.43K |
+22.72% |
| 2015-03-31 | Rs4.25 Million ≈ $45.98K |
+20.62% |
| 2014-03-31 | Rs3.52 Million ≈ $38.12K |
+4795.83% |
| 2013-03-31 | Rs72.00K ≈ $778.65 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ajooni Biotech Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 12010100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs120.07 Million | 13.63% |
| Common Stock | Rs344.49 Million | 39.11% |
| Other Comprehensive Income | Rs-15.63 Million | -1.77% |
| Other Components | Rs431.86 Million | 49.03% |
| Total Equity | Rs880.79 Million | 100.00% |
Ajooni Biotech Limited Competitors by Market Cap
The table below lists competitors of Ajooni Biotech Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Renoworks Software Inc
V:RW
|
$7.82 Million |
|
WH Smith PLC
LSE:SMWH
|
$7.83 Million |
|
Theriva Biologics Inc.
NYSE MKT:TOVX
|
$7.83 Million |
|
Forum Energy Metals Corp
V:FMC
|
$7.83 Million |
|
Intertainment AG
XETRA:ITN
|
$7.82 Million |
|
Kibo Energy PLC
JSE:KBO
|
$7.82 Million |
|
Lincoln Mining Corp
V:LMG
|
$7.81 Million |
|
UNITEDLABELS Aktiengesellschaft
F:ULC
|
$7.80 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ajooni Biotech Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 427,085,000 to 880,789,000, a change of 453,704,000 (106.2%).
- Net income of 32,380,000 contributed positively to equity growth.
- Share repurchases of 253,889,000 reduced equity.
- New share issuances of 253,889,000 increased equity.
- Other comprehensive income decreased equity by 2,611,000.
- Other factors increased equity by 423,935,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs32.38 Million | +3.68% |
| Share Repurchases | Rs253.89 Million | -28.83% |
| Share Issuances | Rs253.89 Million | +28.83% |
| Other Comprehensive Income | Rs-2.61 Million | -0.3% |
| Other Changes | Rs423.94 Million | +48.13% |
| Total Change | Rs- | 106.23% |
Book Value vs Market Value Analysis
This analysis compares Ajooni Biotech Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.87x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2151.84x to 0.87x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-03-31 | Rs0.00 | Rs4.20 | x |
| 2014-03-31 | Rs0.10 | Rs4.20 | x |
| 2015-03-31 | Rs0.12 | Rs4.20 | x |
| 2016-03-31 | Rs0.14 | Rs4.20 | x |
| 2017-03-31 | Rs0.26 | Rs4.20 | x |
| 2018-03-31 | Rs2.97 | Rs4.20 | x |
| 2019-03-31 | Rs3.15 | Rs4.20 | x |
| 2020-03-31 | Rs3.00 | Rs4.20 | x |
| 2021-03-31 | Rs2.76 | Rs4.20 | x |
| 2022-03-31 | Rs2.89 | Rs4.20 | x |
| 2023-03-31 | Rs9.01 | Rs4.20 | x |
| 2024-03-31 | Rs4.30 | Rs4.20 | x |
| 2025-03-31 | Rs4.82 | Rs4.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ajooni Biotech Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.68%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.82%
- • Asset Turnover: 1.21x
- • Equity Multiplier: 1.08x
- Recent ROE (3.68%) is below the historical average (6.39%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -12.50% | 0.00% | 0.00x | 1.03x | Rs-16.20K |
| 2014 | 2.18% | 1.35% | 1.14x | 1.41x | Rs-275.50K |
| 2015 | 17.12% | 1.01% | 4.47x | 3.79x | Rs302.80K |
| 2016 | 18.49% | 0.73% | 5.45x | 4.65x | Rs443.20K |
| 2017 | 28.45% | 0.97% | 2.22x | 13.26x | Rs1.79 Million |
| 2018 | 3.53% | 0.91% | 2.19x | 1.76x | Rs-7.08 Million |
| 2019 | 3.38% | 1.03% | 2.18x | 1.50x | Rs-8.05 Million |
| 2020 | 2.18% | 0.87% | 1.74x | 1.45x | Rs-12.42 Million |
| 2021 | 2.38% | 0.73% | 1.82x | 1.79x | Rs-11.92 Million |
| 2022 | 6.40% | 1.42% | 2.55x | 1.77x | Rs-5.89 Million |
| 2023 | 2.70% | 1.51% | 1.27x | 1.41x | Rs-30.42 Million |
| 2024 | 5.06% | 2.70% | 1.69x | 1.11x | Rs-21.10 Million |
| 2025 | 3.68% | 2.82% | 1.21x | 1.08x | Rs-55.70 Million |
Industry Comparison
This section compares Ajooni Biotech Limited's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $23,812,762,904
- Average return on equity (ROE) among peers: 15.07%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ajooni Biotech Limited (AJOONI) | Rs910.85 Million | -12.50% | 0.25x | $7.82 Million |
| ADF Foods Limited (ADFFOODS) | $1.01 Billion | 13.22% | 0.18x | $313.83 Million |
| Agro Tech Foods Limited (ATFL) | $964.98 Million | 14.49% | 0.70x | $365.36 Million |
| Avanti Feeds Limited (AVANTIFEED) | $668.96 Million | -1.80% | 0.71x | $2.03 Billion |
| Adani Wilmar Limited (AWL) | $81.66 Billion | 7.13% | 1.57x | $2.75 Billion |
| Bombay Burmah Trading Corporation Limited (BBTC) | $56.67 Billion | 4.90% | 0.48x | $1.13 Billion |
| Mrs. Bectors Food Specialities Limited (BECTORFOOD) | $5.44 Billion | 16.55% | 0.53x | $650.88 Million |
| Bikaji Foods International Limited (BIKAJI) | $14.81 Billion | 13.57% | 0.31x | $1.83 Billion |
| Britannia Industries Limited (BRITANNIA) | $43.81 Billion | 49.73% | 1.02x | $14.92 Billion |
| CCL Products (India) Limited (CCL) | $9.28 Billion | 17.87% | 0.63x | $1.64 Billion |
About Ajooni Biotech Limited
Ajooni Biotech Limited manufactures and sells cattle feed in India. Its portfolio includes cattle feed chips, camel and pig feed, cotton oil cakes, mustard oil cakes, and feed supplements. The company was incorporated in 2010 and is based in Mohali, India.